RU2006143842A - NEW SUBSTITUTED THIOPHENCARBOXAMIDES, THEIR PRODUCTION AND USE thereof AS MEDICINES - Google Patents
NEW SUBSTITUTED THIOPHENCARBOXAMIDES, THEIR PRODUCTION AND USE thereof AS MEDICINES Download PDFInfo
- Publication number
- RU2006143842A RU2006143842A RU2006143842/04A RU2006143842A RU2006143842A RU 2006143842 A RU2006143842 A RU 2006143842A RU 2006143842/04 A RU2006143842/04 A RU 2006143842/04A RU 2006143842 A RU2006143842 A RU 2006143842A RU 2006143842 A RU2006143842 A RU 2006143842A
- Authority
- RU
- Russia
- Prior art keywords
- group
- alkyl
- atom
- general formula
- substituted
- Prior art date
Links
- 0 C*(C=C(*)C(*)=C1)C=C1N(*)C(C(*)(*)NC(c1ccc(*)[s]1)=O)=O Chemical compound C*(C=C(*)C(*)=C1)C=C1N(*)C(C(*)(*)NC(c1ccc(*)[s]1)=O)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (15)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04011384 | 2004-05-13 | ||
EP04011384.7 | 2004-05-13 | ||
EP04018807 | 2004-08-07 | ||
EP04018807.0 | 2004-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2006143842A true RU2006143842A (en) | 2008-08-20 |
Family
ID=34969085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2006143842/04A RU2006143842A (en) | 2004-05-13 | 2005-05-07 | NEW SUBSTITUTED THIOPHENCARBOXAMIDES, THEIR PRODUCTION AND USE thereof AS MEDICINES |
Country Status (13)
Country | Link |
---|---|
US (1) | US7476663B2 (en) |
EP (1) | EP1747217A1 (en) |
JP (1) | JP2007537180A (en) |
KR (1) | KR20070012552A (en) |
AR (1) | AR048959A1 (en) |
AU (1) | AU2005243535A1 (en) |
BR (1) | BRPI0510019A (en) |
CA (1) | CA2564207A1 (en) |
IL (1) | IL179170A0 (en) |
MX (1) | MXPA06013213A (en) |
RU (1) | RU2006143842A (en) |
TW (1) | TW200604178A (en) |
WO (1) | WO2005111029A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007537179A (en) * | 2004-05-13 | 2007-12-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Substituted thiophene-2-carboxylic acid amides, their preparation and use as drugs |
EP1748996A1 (en) * | 2004-05-13 | 2007-02-07 | Boehringer Ingelheim International GmbH | Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug |
DE102004062544A1 (en) * | 2004-12-24 | 2006-07-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel substituted pyrrolidinones, their preparation and their use as pharmaceuticals |
PE20070171A1 (en) | 2005-06-30 | 2007-03-08 | Boehringer Ingelheim Int | SUBSTITUTE GLYCINAMIDES WITH ANTITHROMBOTIC EFFECT AND INHIBITOR OF FACTOR Xa |
PE20081834A1 (en) * | 2006-12-31 | 2009-01-16 | Boehringer Ingelheim Int | PROCESS FOR THE SYNTHESIS OF 3-AMINO-TETRAHIDROFURAN-3-CARBOXILICO ACID DERIVATIVES AND USE OF SAME AS MEDICINES |
JP5524852B2 (en) | 2007-11-15 | 2014-06-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Substituted amides, their production and use as pharmaceuticals |
WO2009119528A1 (en) * | 2008-03-24 | 2009-10-01 | 武田薬品工業株式会社 | Heterocyclic compound |
US20100168377A1 (en) * | 2008-12-29 | 2010-07-01 | Carter Technologies | Catalytic conversion of amide compounds to methyl ether polymers and methyl ether ladder polymers |
ITBO20090078A1 (en) | 2009-02-13 | 2010-08-14 | Consiglio Nazionale Ricerche | COMPOUNDS FOR TREATING TUMOR TO THE PROSTATE AND PROCEDURES FOR THEIR SYNTHESIS |
US8278302B2 (en) | 2009-04-08 | 2012-10-02 | Boehringer Ingelheim International Gmbh | Substituted piperidines as CCR3 antagonists |
WO2010123792A1 (en) * | 2009-04-20 | 2010-10-28 | Osi Pharmaceuticals, Inc. | Preparation of c-pyrazine-methylamines |
EP2630143B1 (en) * | 2010-10-18 | 2017-11-29 | Apotex Pharmachem Inc. | Processes for the preparation of rivaroxaban and intermediates thereof |
US8912221B2 (en) * | 2010-12-27 | 2014-12-16 | Hoffmann-La Roche Inc. | Biaryl amide derivatives |
WO2012149102A1 (en) * | 2011-04-29 | 2012-11-01 | Glaxosmithkline Llc | Novel compounds as wip1 inhibitors |
GB201820166D0 (en) * | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
US11795147B2 (en) | 2019-08-26 | 2023-10-24 | Boehringer Ingelheim International Gmbh | Modulators of complex I |
CN116406266A (en) | 2020-11-06 | 2023-07-07 | 勃林格殷格翰国际有限公司 | 2- [ (thiophen-2-yl) carboxamido ] -N- (phenyl) -2-methylpropanamide derivatives and their use as pharmaceuticals |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19962924A1 (en) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituted oxazolidinones and their use |
GB0030304D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
GB0030305D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
DE10063008A1 (en) | 2000-12-16 | 2002-06-20 | Merck Patent Gmbh | carboxamide |
MY130373A (en) * | 2001-10-29 | 2007-06-29 | Malesci Sas | Linear basic compounds having nk-2 antagonist activity and formulations thereof |
EP1558606A4 (en) | 2002-10-02 | 2008-05-07 | Bristol Myers Squibb Co | Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
DE10254336A1 (en) * | 2002-11-21 | 2004-06-03 | Merck Patent Gmbh | carboxamides |
DE10301419A1 (en) * | 2003-01-16 | 2004-07-29 | Bayer Cropscience Ag | spiro compounds |
-
2005
- 2005-05-07 RU RU2006143842/04A patent/RU2006143842A/en not_active Application Discontinuation
- 2005-05-07 JP JP2007512051A patent/JP2007537180A/en active Pending
- 2005-05-07 AU AU2005243535A patent/AU2005243535A1/en not_active Abandoned
- 2005-05-07 MX MXPA06013213A patent/MXPA06013213A/en active IP Right Grant
- 2005-05-07 WO PCT/EP2005/004975 patent/WO2005111029A1/en active Application Filing
- 2005-05-07 EP EP05747401A patent/EP1747217A1/en not_active Withdrawn
- 2005-05-07 BR BRPI0510019-4A patent/BRPI0510019A/en not_active IP Right Cessation
- 2005-05-07 CA CA002564207A patent/CA2564207A1/en not_active Abandoned
- 2005-05-07 KR KR1020067026224A patent/KR20070012552A/en not_active Application Discontinuation
- 2005-05-10 US US11/125,731 patent/US7476663B2/en active Active
- 2005-05-12 TW TW094115321A patent/TW200604178A/en unknown
- 2005-05-13 AR ARP050101961A patent/AR048959A1/en unknown
-
2006
- 2006-11-09 IL IL179170A patent/IL179170A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0510019A (en) | 2007-09-25 |
AU2005243535A1 (en) | 2005-11-24 |
CA2564207A1 (en) | 2005-11-24 |
US7476663B2 (en) | 2009-01-13 |
EP1747217A1 (en) | 2007-01-31 |
MXPA06013213A (en) | 2007-02-08 |
WO2005111029A1 (en) | 2005-11-24 |
TW200604178A (en) | 2006-02-01 |
US20050277628A1 (en) | 2005-12-15 |
KR20070012552A (en) | 2007-01-25 |
JP2007537180A (en) | 2007-12-20 |
IL179170A0 (en) | 2007-03-08 |
AR048959A1 (en) | 2006-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2006143842A (en) | NEW SUBSTITUTED THIOPHENCARBOXAMIDES, THEIR PRODUCTION AND USE thereof AS MEDICINES | |
RU2001117757A (en) | Substituted benzimidazoles and their use as poly (adenosine diphosphatribose) polymerase inhibitors | |
RU2008112691A (en) | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ITS PHARMACEUTICAL APPLICATION | |
RU2350605C2 (en) | Analogues of quinazoline as inhibitors of receptor tyrosine kinases | |
EA200500312A1 (en) | NEW SPIROCONDENSED HINASOLINONES AND THEIR APPLICATION AS PHOSPHODYESTERES INHIBITORS | |
HUP0201088A2 (en) | New alpha-amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them | |
RU2006112593A (en) | 2, 4-DI (HETERO) ARILAMINOPYRIMIDINE DERIVATIVES AS ZAP-70 AND / OR SYK INHIBITORS | |
RU2003110577A (en) | HETEROCYCLIC COMPOUNDS CONNECTING TO CHEMOKINE RECEPTORS | |
PE20070138A1 (en) | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ASPARTILE PROTEASES | |
CA2445190A1 (en) | Indole, azaindole and related heterocyclic amidopiperazine derivatives | |
RU2008123839A (en) | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | |
EA200200446A1 (en) | NEW α-AMINO ACID COMPOUNDS, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS, THEIR CONTAINING | |
RU2008125158A (en) | HETEROCYCLIC COMPOUNDS HAVING INHIBITING ACTIVITY WITH RESPECT TO TYPE 11-HYDROXYSTEROID DEHYDROHENASE 1 | |
ATE464286T1 (en) | CYCLOPROPANE DERIVATIVES AND THEIR PHARMACEUTICAL USE | |
RU2011101774A (en) | NEW SUBSTITUTED PYRIDINE-2-ONES AND PYRIDAZIN-3-ONES | |
RU2010148570A (en) | CYCLIC INHIBITORS 11BETA-HYDROXYSTEROID-DEHYDROGENASE 1 | |
JP2006517220A5 (en) | ||
EA200600513A1 (en) | BICYCLIC [3.1.0] DERIVATIVES AS AN INHIBITORS OF GLYCIN TRANSFERERS | |
RU2014141579A (en) | Heterocyclic compounds as beta-lactamase inhibitors | |
RU2004109812A (en) | 2-cyano-4-aminopyrimidine cysteine protease inhibitors with an inhibitory effect on cathepsin K for the treatment of inflammatory and other diseases | |
JP2004537564A5 (en) | ||
RU2007130144A (en) | HETEROCYCLIC COMPOUNDS AS CCCR2B ANTAGONISTS | |
RU2013119129A (en) | ORGANIC COMPOUNDS | |
ATE380030T1 (en) | ANTIVIRAL BICYCLO 4.4.0 DERIVATIVES | |
RU2010130418A (en) | 4-AMINOPYRIMIDINE DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20110615 |